Jeong, Daeun
Danielli, Sara G. https://orcid.org/0000-0003-3101-3114
Maaß, Kendra K.
Ghasemi, David R. https://orcid.org/0000-0002-3844-9933
Tetzlaff, Svenja K. https://orcid.org/0000-0002-2893-920X
Reyhan, Ekin
Jiang, Li
Katiyar, Shashank https://orcid.org/0009-0004-2265-2883
Sundheimer, Julia K.
Lo Cascio, Costanza
Neyazi, Sina https://orcid.org/0000-0002-9861-2325
de Biagi-Junior, Carlos Alberto Oliveira https://orcid.org/0000-0003-0700-3135
Couvillon, Elsa https://orcid.org/0009-0009-1682-1579
Castellani, Sophia
Pazyra-Murphy, Maria
Mullally, Matthew
Dehler, Marc Philipp https://orcid.org/0009-0000-7129-1181
Englinger, Bernhard
Nascimento, Andrezza
Cruzeiro, Gustavo Alencastro Veiga
Marques, Joana G. https://orcid.org/0000-0001-7152-9655
Haase, Rebecca D.
Nguyen, Cuong M.
Baumgartner, Alicia-Christina
Rozowsky, Jacob S.
Hack, Olivia A.
Shaw, McKenzie L.
Lotsch-Gojo, Daniela
Bruckner, Katharina https://orcid.org/0000-0002-6633-4009
Korshunov, Andrey
Pfister, Stefan M. https://orcid.org/0000-0002-5447-5322
Kool, Marcel https://orcid.org/0000-0002-6557-5468
Nowakowski, Tomasz J. https://orcid.org/0000-0003-2345-4964
Gojo, Johannes https://orcid.org/0000-0002-8113-3416
Baird, Lissa https://orcid.org/0000-0001-7996-1020
Alexandrescu, Sanda
Pajtler, Kristian W. https://orcid.org/0000-0002-3562-6121
Venkataramani, Varun https://orcid.org/0000-0002-2927-0886
Filbin, Mariella G. https://orcid.org/0000-0002-2613-8126
Article History
Received: 7 August 2024
Accepted: 30 January 2026
First Online: 11 March 2026
Competing interests
: M.G.F. is a consultant for Twentyeight-Seven Therapeutics and Blueprint Medicines. The other authors declare no competing interests.